Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals
Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
Corporate Spotlight
Not Yet Available
Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.
Latest Threads
Tag | Subject | ||||||
---|---|---|---|---|---|---|---|
ITL | Ann: Removal from Official List - Close of business 15 June 2018 | 15/06/18 | 0 | 928 | |||
|
|||||||
ITL | Ann: Suspension from Official Quotation-Close of trading 13/6/18 | 13/06/18 | 0 | 1.4K | |||
|
|||||||
ITL | Ann: Final Director's Interest Notice | 31/05/18 | 0 | 680 | |||
|
|||||||
ITL | Ann: Results of Annual General Meeting | 31/05/18 | 0 | 1.3K | |||
|
|||||||
ITL | News: ITL Integrated Media Technology Ltd Says Unit Enters Share Subscription Agreement | 25/05/18 | 0 | 482 | |||
|
|||||||
ITL | Ann: Subsidiary enters into Share Subscription Agreement | 25/05/18 | 0 | 1.4K | |||
|
|||||||
ITL | 9 bagger arbitrage opp vs NASDAQ listing? | 15/05/18 | 6 | 14K | |||
|
|||||||
ITL | Ann: Reinstatement to Official Quotation | 04/05/18 | 0 | 1.7K | |||
|
See All Discussions